Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective is to evaluate the effectiveness of two treatment regimens by assessing the average BCVA change from Month 4 to Month 12 compared to Month 3 based on both, BCVA stability in each treatment group and comparison of the two treatment groups. For the analysis of these objectives a reference margin of two letters will be applied. A treatment regimen will be considered a relevant option if stability is achieved and non-inferiority compared to the other group is demonstrated.
Inclusion criteria
- Visual impairment due to neovascular AMD